Cap-dependent endonuclease-IN-7

Catalog No. :
ACKCVK762
CAS No. :
2485715-97-5
Molecular Formula :
C36H28FN3O7S
Molecular Weight :
665.70

IUPAC Name:(((R)-12-((S)-5-fluoro-2-phenyl-8H-dibenzo[3,4:6,7]cyclohepta[1,2-b]thiophen-8-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate

Cap-dependent endonuclease-IN-7 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameCap-dependent endonuclease-IN-7
IUPAC Name(((R)-12-((S)-5-fluoro-2-phenyl-8H-dibenzo[3,4:6,7]cyclohepta[1,2-b]thiophen-8-yl)-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl)oxy)methyl methyl carbonate
Molecular FormulaC36H28FN3O7S
Molecular Weight665.70
SMILESO=C(OCOC(C(C=C1)=O)=C(N1N([C@H](C2=CC=CC=C23)C4=CC=C(F)C=C4C5=C3SC(C6=CC=CC=C6)=C5)[C@@]7([H])N8CCOC7)C8=O)OC
InChI KeyWNRPSAKVRGSUJM-FIRIVFDPSA-N
SynonymCarbonic acid, [[(12aR)-12-[(8S)-5-fluoro-2-phenyl-8H-dibenzo[3,4:6,7]cyclohepta[1,2-b]thien-8-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl]oxy]methyl methyl ester;Cap-dependent endonuclease-IN-7
CAS No.2485715-97-5

Synthetic Route by SureRoute

1. ACKCVK762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKCVK762 route product structure diagram
    ACKCVK7622485715-97-5
Inquiry

2. ACKCVK762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKCVK762 route product structure diagram
    ACKCVK7622485715-97-5
Inquiry

Comments (0)